Clinical trial
Trial of Decitabine in Patients With Acute Myeloid Leukemia
NCT00260832 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00260832 |
|---|---|
| Title | Trial of Decitabine in Patients With Acute Myeloid Leukemia |
| Official title | Randomized Phase 3 Trial of Decitabine Versus Patient's Choice With Physician's Advice of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Cytarabine or Supportive Care, Dacogen (decitabine) only |
| Enrollment | 485 |
| Start date | Nov 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Dec 2, 2005 |
| Last update posted | Sep 11, 2019 |
| Countries | Australia, Canada, Croatia, Czechia, France, Hungary, Mexico, Poland, Romania, Russia, Serbia, Spain and 3 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: